Skip to main content

Advertisement

Fig. 5 | Microbial Cell Factories

Fig. 5

From: Protective effect of TSLP delivered at the gut mucosa level by recombinant lactic acid bacteria in DSS-induced colitis mouse model

Fig. 5

Short and early LL-TSLP administration reduced inflammation during DSS-induced colitis. a Schematic representation of bacterial administration protocol. b Percentage initial weight. c DAI of mice treated with LL-WT or LL TSLP early phase. d Histological score. e TGF-β and f IL-17 concentrations in supernatants of anti-CD3 and anti-CD-28 activated cells from MLN

Back to article page